Carl Hoh

Carl Hoh

Auto-generated profile, based on publicly available information

Carl Hoh

Univ. of California, San Diego, CA 92093

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
AGAaron M. Goodman
Aaron M. Goodman
KHKimberly A. Holden
Kimberly A. Holden
Ah-Reum JeongAh-Reum Jeong
Ah-Reum Jeong
LKLisa Kim
Lisa Kim
KFKerry D. Fitzgerald
Kerry D. Fitzgerald
RKRazelle Kurzrock
Razelle Kurzrock
Methods that enable monitoring of therapeutic efficacy of autologous chimeric antigen receptor (CAR) T-cell therapy will be clinically useful. The aim of this study is to demonstrate the feasibility of blood-derived cell-free DNA (cfDNA) to predict CAR T-cell therapy response in patients with refractory B-cell lymphomas. Whole blood was collected before and throughout CAR T-cell therapy until day 154. Low-coverage (∼0.4×), genome-wide cfDNA sequencing, similar to that established for noninvasive prenatal testing, was performed. The genomic instability number (GIN) was used to quantify plasma copy number alteration level. Twelve patients were enrolled. Seven (58%) patients achieved a complete response (CR); 2 (25%), a partial response. Median progression-free survival was 99 days; median overall survival was not reached (median follow-up, 247 days). Altogether, 127 blood samples were analyzed (median, 10 samples/patient [range 8-13]). All 5 patients who remained in CR at the time of last measurement had GIN 170. In 5 of 6 patients with relapsed or progressive disease, increasing GIN was observed before the diagnosis by imaging. The abundance of CAR T-cell construct (absolute number of construct copies relative to the number of human genome equivalents) also showed a trend to correlate with outcome (day 10, P = .052). These data describe a proof-of-concept for the use of multiple liquid biopsy technologies to monitor therapeutic response in B-cell lymphoma patients receiving CAR T-cell therapy.

1 September 2010 in The Journal of the Acoustical Society of America
Verified
Journal Article
Closed access
DHDorian S. Houser
Dorian S. Houser
PMPatrick W. Moore
Patrick W. Moore
Shawn JohnsonShawn Johnson
Shawn Johnson
BLBetsy Lutmerding
Betsy Lutmerding
BBBrian Branstetter
Brian Branstetter
CHCarl Hoh
Carl Hoh
Odontocete braintissues associated with auditory processing are hypertrophied and modified relative to their terrestrial counterparts. The relationship between the functional demand on these tissues and metabolic substrate requirements is unknown. Using positron emission tomography(PET), relative cerebral blood flow was measured in a bottlenose dolphin. Approximately 60 mCi N 13 H 3 was administered to the dolphin via a catheter inserted into the hepatic vein and threaded proximate to the vena cava. Radiolabel initially appeared as distributed focal points in the cerebellum. Increasing scan time resulted in an increase in the number of focal regions and in the diffusivity of label activity throughout the brain. The time course and spatial distribution of radiolabel was consistent with a cerebral blood supply dominated by the spinal meningeal arteries.Blood flow was predominantly observed in the cerebellum and neocortex, particularly the auditory and visual cortex. Differential brain glucose uptake, previously measured in a separate dolphin, showed good agreement with the differential supply of blood to braintissues. Rates of blood supply and glucose uptake in the auditory cortex, inferior colliculus, and cerebellum are consistent with a high metabolic demand of tissues which are important to the integration of auditory and other sensory inputs.

9 December 2020 in EJNMMI Research
Verified
Journal Article
Open access
PDF file
AJAmin Haghighat Jahromi
Amin Haghighat Jahromi
DBDonald A. Barkauskas
Donald A. Barkauskas
MZMatthew Zabel
Matthew Zabel
AGAaron M. Goodman
Aaron M. Goodman
GFGarret Frampton
Garret Frampton
RKRazelle Kurzrock
Razelle Kurzrock
Purpose: Deriving links between imaging and genomic markers is an evolving field. 2-[18F]FDG PET/CT (18F-fluorodeoxyglucose positron emission tomography–computed tomography) is commonly used for cancer imaging, with maximum standardized uptake value (SUVmax) as the main quantitative parameter. Tumor mutational burden (TMB), the quantitative variable obtained using next-generation sequencing on a tissue biopsy sample, is a putative immunotherapy response predictor. We report the relationship between TMB and SUVmax, linking these two important parameters. Methods: In this pilot study, we analyzed 1923 patients with diverse cancers and available TMB values. Overall, 273 patients met our eligibility criteria in that they had no systemic treatment prior to imaging/biopsy, and also had 2-[18F]FDG PET/CT within 6 months prior to the tissue biopsy, to ensure acceptable temporal correlation between imaging and genomic evaluation. Results: We found a linear correlation between TMB and SUVmax (p < 0.001). In the multivariate analysis, only TMB independently correlated with SUVmax, whereas age, gender, and tumor organ did not. Conclusion: Our observations link SUVmax in readily available, routinely used, and noninvasive 2-[18F]FDG PET/CT imaging to the TMB, which requires a tissue biopsy and time to process. Since higher TMB has been implicated as a prognostic biomarker for better outcomes after immunotherapy, further investigation will be needed to determine if SUVmax can stratify patient response to immunotherapy.

1 April 1993 in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
Verified
Journal Article
Closed access
PDF file
ENE. U. Nitzsche
E. U. Nitzsche
CHC. K. Hoh
C. K. Hoh
NDN. M. Dalbohm
N. M. Dalbohm
JGJ. A. Glaspy
J. A. Glaspy
MPM. E. Phelps
M. E. Phelps
RHR. A. Hawkins
R. A. Hawkins
Der Stellenwert der Ganzkörper-Positronen-Emissions-Tomographie mit F-18-2-Deoxy-2-Fluoro-D-Glukose wurde bei 37 Patienten mit primärem bzw. metastasiertem Mammakarzinom in der Primärdiagnostik bzw. Verlaufskontrolle prospektiv untersucht. Von 20 Patientinnen mit Verdacht auf ein primäres Mammakarzinom wurden in Korrelation zur Histologie 15 von 16 malignen und 4 von 4 benignen Tumoren diagnostiziert. Bei 3 von 21 Patientinnen mit metastasierter Erkrankung wurde in Korrelation zur morphologisch-bild-gebenden Diagnostik/Biopsie ein falsch-negativer Befund erhoben. Diese initialen Ergebnisse lassen die Ganzkörper-Positronen-Emissions-Tomographie zur Erfassung des Krankheitsstadiums beim Mammakarzinom als ein geeignetes bildgebendes Stagingverfahren erscheinen. The value of whole body positron emission tomography using F-18 2-deoxy-2-fluoro-d-glucose in primary work-up and follow-up was prospectively evaluated in 37 patients with primary or metastatic breast cancer. From 20 primary breast masses 15 from 16 malignant and 4 from 4 benign lesions confirmed by biopsy, were detected. In 3 out of 21 patients in correlation to morphologic imaging, respectively biopsy, no metastatic disease was not identified. Generally speaking, whole body positron emission tomography appears to be a suitable diagnostic staging tool in breast cancer.

1 May 2006 in The Journal of the Acoustical Society of America
Verified
Journal Article
Closed access
SRSam Ridgway
Sam Ridgway
BBBrad Blankenship
Brad Blankenship
DHDorian S. Houser
Dorian S. Houser
DCDon Carder
Don Carder
CHCarl Hoh
Carl Hoh

1 October 2003 in The Journal of the Acoustical Society of America
Verified
Journal Article
Closed access
DHDorian S. Houser
Dorian S. Houser
JFJames J. Finneran
James J. Finneran
RMRobert Mattrey
Robert Mattrey
CHCarl Hoh
Carl Hoh
SRSam Ridgway
Sam Ridgway